ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,693Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 139

$546K Total Retail Price of All Prescriptions

Rank: 12 out of 139

454 Patients Receiving at Least One Drug in Part D
29%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

52% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 29%.

Risky Drugs to Seniors

1% of this provider’s 2,912 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 668 199 S3 1 1
PROAIR HFA 528 97 2 10
AMLODIPINE BESYLATE 453 173 3 4
CARISOPRODOL 331 27 R 4 14
OXYCODONE HCL 326 109 S2 5 17
LISINOPRIL 312 97 6 2
ADVAIR DISKUS 306 74 7 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 284 71 8 25
CLONIDINE HCL 265 69 9 21
SIMVASTATIN 261 136 10 3
OMEPRAZOLE 224 84 11 5
NEXIUM 159 35 12 49
METFORMIN HCL 158 40 13 8
RANITIDINE HCL 155 32 14 15
METOPROLOL TARTRATE 152 70 15 9
POTASSIUM CHLORIDE 144 56 16 12
FUROSEMIDE 138 65 17 7
FLUTICASONE PROPIONATE 129 0 18 46
IBUPROFEN 122 22 19 20
GABAPENTIN 110 32 20 13
CARVEDILOL 103 20 21 22
HYDROCHLOROTHIAZIDE 100 45 22 11
VENTOLIN HFA 92 32 23 44
ATENOLOL 81 43 24 18
SPIRIVA 68 29 25 45
LEVOTHYROXINE SODIUM 67 34 26 6
BETAMETHASONE DIPROPIONATE 67 17 26 241
TRIAMTERENE-HCTZ 65 27 28 50
PLAVIX 62 23 29 52
NITROSTAT 61 32 30 147
VOLTAREN 58 22 31 86
LANTUS 57 25 32 35
NASONEX 55 13 33 134
BENZTROPINE MESYLATE 55 0 R 33 167
ZOLPIDEM TARTRATE 51 16 35 27
LIDODERM 51 33 35 47
ATORVASTATIN CALCIUM 51 12 35 23
SERTRALINE HCL 51 0 35 29
QUETIAPINE FUMARATE 51 0 35 59
ISOSORBIDE MONONITRATE ER 50 32 40 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.